Stay updated on NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial
Sign up to get notified when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.

Latest updates to the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page
- Check6 days agoChange DetectedOnly the revision label was updated from v3.3.1 to v3.3.2, with no changes to study details, inclusion/exclusion criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision: v3.3.1 replaces v3.2.0 on the page.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page deleted a government funding and operating status notice that previously appeared on the study record. The removal does not affect core trial information such as eligibility criteria, interventions, outcomes, or listed locations; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedAddition of related-topic tags for Schizophrenia and MedlinePlus Genetics to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check57 days agoChange DetectedAdded new MedlinePlus Genetics topic: Schizophrenia; no deletions.SummaryDifference0.3%

- Check64 days agoChange DetectedUpdate includes a new operating-status notice and version bump to v3.2.0; a topic on Schizophrenia under MedlinePlus Genetics was removed.SummaryDifference6%

Stay in the know with updates to NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.